Hematology

Recruiting NCT03874052☆ Save

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase I Interventional United States

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Recurrent Secondary Acute Myeloid Leukemia

Recruiting NCT07019155☆ Save

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

— Observational United States

Germline Mutation · Myelodysplastic Syndromes · Acute Myeloid Leukemia

Recruiting NCT07325305☆ Save

Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes

No phase Interventional Australia

Sarcopenia · Acute Lymphoblastic Leukemia

Recruiting NCT05907759☆ Save

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase II Interventional United States

Lymphoma, Primary Effusion

Recruiting NCT05552222☆ Save

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Phase III Interventional United States, Australia +23

Multiple Myeloma

Not yet recruiting NCT06930352☆ Save

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

Phase II Interventional United States

Acute Myeloid Leukemia

Recruiting NCT03501576☆ Save

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

— Observational United States

Chronic Lymphocytic Leukemia · Diffuse Large B-Cell Lymphoma · Follicular Lymphoma

Recruiting NCT02332668☆ Save

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Phase I / Phase II Interventional United States, Brazil +8

Melanoma · Lymphoma · Solid Tumor

Not yet recruiting NCT07684950☆ Save

Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

Phase II Interventional China

Mantle Cell Lymphoma (MCL)

Recruiting NCT04815356☆ Save

Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

Phase I Interventional United States

Hairy Cell Leukemia · Hairy Cell Leukemia Variant

Recruiting NCT07684131☆ Save

EWALL-PH OBSERVARTORY 2022

— Observational France

Acute Lymphoblastic Leukemia

Not yet recruiting NCT07013435☆ Save

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

No phase Interventional United States

Lymphoma

Recruiting NCT06299540☆ Save

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

— Observational France

Leukemia, Lymphocytic, Chronic, B-Cell

Recruiting NCT05652335☆ Save

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Phase I Interventional United States, Belgium +5

Relapsed or Refractory Multiple Myeloma · Previously Treated Amyloid Light-chain (AL) Amyloidosis

Recruiting NCT02889003☆ Save

Second STOP After Pioglitazone Priming in CML Patients

Phase II Interventional France

Chronic Myeloid Leukemia (CML)

Recruiting NCT05805605☆ Save

Allo HSCT Using RIC and PTCy for Hematological Diseases

Phase II Interventional United States

Acute Myelogenous Leukemia · Acute Lymphocytic Leukemia · Biphenotypic Acute Leukemia

Recruiting NCT06083922☆ Save

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Phase II Interventional United States

Multiple Myeloma · Monoclonal Gammopathy of Renal Significance

Not yet recruiting NCT07605416☆ Save

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Phase II Interventional —

Plasma Cell Leukemia

Recruiting NCT06697600☆ Save

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

No phase Interventional United States

Oncology · Myeloid Leukemia, Acute · Cancer

Not yet recruiting NCT07684274☆ Save

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

— Observational —

Multiple Myeloma (MM) · Smoldering Multiple Myeloma (SMM) · MGUS

Recruiting NCT07586735☆ Save

A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA

— Observational China

Severe Aplastic Anemia · Aplastic Anaemia · Hematopoietic Cell Transplant

Not yet recruiting NCT07682792☆ Save

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Phase II Interventional United States

Mycosis Fungoides/Sezary Syndrome · T-cell Large Granular Lymphocytic Leukemia

Recruiting NCT05160584☆ Save

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

— Observational Austria, Belgium +10

Relapsed/Refractory Multiple Myeloma

Recruiting NCT06377540☆ Save

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Phase II Interventional United States

Autologous Stem Cell Transplant · Classic Hodgkin Lymphoma

Recruiting NCT04877522☆ Save

Asciminib Roll-over Study

Phase IV Interventional United States, Argentina +27

Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Recruiting NCT07685717☆ Save

Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia

Phase II Interventional United States

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Recruiting NCT07602088☆ Save

A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia

— Observational Romania

Leukemia, Lymphocytic, Chronic, B-Cell

Recruiting NCT01351545☆ Save

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

— Observational United States

Hematologic Malignancies · Inherited Disorders of Metabolism · Inherited Abnormalities of Platelets

Recruiting NCT07188610☆ Save

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Phase II Interventional China

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

Recruiting NCT06651229☆ Save

A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms

Phase I Interventional Australia, France +1

Leukemia, Myeloid, Acute · Myelodysplastic Neoplasms

Not yet recruiting NCT07681596☆ Save

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Phase I / Phase II Interventional United States, Australia

Relapsed or Refractory Multiple Myeloma

Recruiting NCT06738368☆ Save

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

Phase II Interventional United States

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · T Acute Lymphoblastic Leukemia

Recruiting NCT07585760☆ Save

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Phase II Interventional China

Multiple Myeloma (MM) · Multiple Myeloma Light Chain Induced Renal Insufficiency

Recruiting NCT05131022☆ Save

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Phase I Interventional United States, France +6

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Diffuse Large B Cell Lymphoma (DLBCL)

Recruiting NCT07073833☆ Save

The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma

Phase I Interventional China

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Recruiting NCT02560883☆ Save

Hairy Cell Leukemia Patient Data Registry

— Observational United States, Australia +1

Leukemia, Other

Not yet recruiting NCT07549841☆ Save

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

Phase II Interventional France

Transthyretin Cardiac Amyloidosis

Recruiting NCT06234904☆ Save

Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Phase I Interventional China

Acute Myeloid Leukemia

Recruiting NCT03412877☆ Save

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Phase II Interventional United States

Endocrine Tumors · Non-Small Cell Lung Cancer · Ovarian Cancer

Recruiting NCT07680933☆ Save

Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Phase II Interventional China

DLBCL - Diffuse Large B Cell Lymphoma

Recruiting NCT07304011☆ Save

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

Phase II Interventional United States

Acute Myeloid Leukemia

Recruiting NCT01174108☆ Save

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Phase II Interventional United States

Severe Aplastic Anemia · MDS (Myelodysplastic Syndrome)

Recruiting NCT07680868☆ Save

Caris Chromoseq Data Collection

— Observational United States

Acute Myeloid Leukemia (AML) · Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases · Myelodysplatic Syndromes

Recruiting NCT03520647☆ Save

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Phase II Interventional United States

Severe Aplastic Anemia (SAA) · Hypo-Plastic Myelodysplastic Syndrome (MDS) · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Not yet recruiting NCT07514819☆ Save

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

No phase Interventional United States

Pediatric Solid Tumors · Rhabdomyosarcoma · Ewing Sarcoma

Recruiting NCT07677878☆ Save

Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

Phase I Interventional China

ALL (Acute B-Lymphoblastic Leukemia)

Not yet recruiting NCT07192471☆ Save

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Phase I Interventional United States, Italy +1

T-cell NHL (PTCL or CTCL)

Recruiting NCT03802695☆ Save

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Phase I Interventional United States

Acute Myeloid Leukemia · Myelodysplastic Syndromes · Mixed Phenotype Acute Leukemia

Recruiting NCT06508463☆ Save

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Phase I Interventional United States

Peripheral T Cell Lymphoma · Relapsed Peripheral T-Cell Lymphoma · Peripheral T-Cell Lymphoma, Not Otherwise Specified

Recruiting NCT04050280☆ Save

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Phase II Interventional United States

Acute Myeloid Leukemia, Adult · Acute Myeloid Leukemia Recurrent · Acute Myeloid Leukemia, Relapsed, Adult

Recruiting NCT06860880☆ Save

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

No phase Interventional United States

Indolent Lymphomas · Lymphoma · Chronic Lymphocytic Leukemia

Recruiting NCT05954910☆ Save

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

— Observational China

Diffuse Large B-Cell Lymphoma

Not yet recruiting NCT07667868☆ Save

A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma

Phase I Interventional —

Relapsed/Refractory Multiple Myeloma (RRMM)

Recruiting NCT07292272☆ Save

Halt Aging in Survivors of Blood Cancers

No phase Interventional United States

Hematological Malignancy · Leukemia · Lymphoid Leukemia

Recruiting NCT07565220☆ Save

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Phase I Interventional United States

Acute Lymphocytic Leukemia (ALL) · Acute Myeloid Leukemia (AML) · Acute Leukemia

Recruiting NCT04356469☆ Save

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

Phase II Interventional United States

Hemoglobinopathy (Disorder) · Severe Aplastic Anemia · Bone Marrow Failure Syndrome

Recruiting NCT04064060☆ Save

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Phase III Interventional United States, Australia +20

Myelodysplastic Syndromes (MDS) · Beta-thalassemia · Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Not yet recruiting NCT07679958☆ Save

Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular Therapy

No phase Interventional Spain

Hematologic Diseases · Hematopoietic Stem Cell Transplantation · Cellular Therapy

Not yet recruiting NCT07677813☆ Save

Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

Phase II Interventional China

DLBCL - Diffuse Large B Cell Lymphoma

Recruiting NCT06812104☆ Save

Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

Phase I Interventional Japan

Relapsed or Refractory AML and Other Hematologic Malignancies

Recruiting NCT07222761☆ Save

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Phase III Interventional United States, Australia +2

Relapsed and/or Refractory Multiple Myeloma (RRMM)

Recruiting NCT04411043☆ Save

Observatory of Prolymphocytic Leukemia T

— Observational France

Prolymphocytic Leukemia · T-cell Leukemia

Not yet recruiting NCT07557056☆ Save

Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase II Interventional United States

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Recruiting NCT06929624☆ Save

A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

Phase III Interventional China

Diffuse Large B-cell Lymphoma

Recruiting NCT06057402☆ Save

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Phase IV Interventional United States, Australia +5

Multiple Myeloma

Recruiting NCT04836507☆ Save

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Phase I / Phase II Interventional South Korea

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)

Not yet recruiting NCT07676877☆ Save

Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma

Phase I Interventional United States

Recurrent Diffuse Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma

Recruiting NCT05389423☆ Save

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Phase I Interventional United States

Diffuse Large Cell Lymphoma · Non-Hodgkin Lymphoma · Burkitt Lymphoma

Not yet recruiting NCT07674810☆ Save

A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia

Phase II Interventional United States

Chronic Lymphocytic Leukemia

Recruiting NCT07675967☆ Save

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

— Observational United States

Lung Cancer (Diagnosis) · Osteochondroma · Spitz Nevus

Recruiting NCT07316010☆ Save

Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Phase II Interventional United States

Large B-cell Lymphoma

Recruiting NCT03932903☆ Save

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

No phase Interventional United States

Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma

Recruiting NCT06897904☆ Save

Basic Hematological Parameters and Coagulation Profile in Type 1 Diabetic Children

— Observational Egypt

Type 1 Diabetes Mellitus

Not yet recruiting NCT07605949☆ Save

Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML

Phase II Interventional United States

Leukemia Acute Myeloid

Not yet recruiting NCT07638787☆ Save

Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL

Phase I / Phase II Interventional China

Large B-cell Lymphoma

Recruiting NCT06357182☆ Save

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

Phase I Interventional United States

Acute Myeloid Leukemia · Myelodysplastic Syndrome/Acute Myeloid Leukemia

Recruiting NCT05600686☆ Save

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

Phase II Interventional United States

Double-Expressor Lymphoma · High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

Recruiting NCT06905509☆ Save

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Phase II Interventional United States

Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements

Not yet recruiting NCT07676006☆ Save

A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Early Phase I Interventional China

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Not yet recruiting NCT07676175☆ Save

A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

Phase II Interventional China

Previously Untreated Peripheral T-Cell Lymphoma

Not yet recruiting NCT07597941☆ Save

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Phase II / Phase III Interventional —

Acute Promyelocytic Leukemia (APL)

Recruiting NCT05323409☆ Save

Improving Comprehensive Care of Cancer Patients

No phase Interventional United States

Breast Cancer · Gastrointestinal Cancer · Hematologic Cancer

Recruiting NCT06465316☆ Save

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Phase I Interventional United States

Recurrent Multiple Myeloma · Refractory Multiple Myeloma

Not yet recruiting NCT07677306☆ Save

Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT

Phase II Interventional China

Myelodysplastic Syndromes

Recruiting NCT04925479☆ Save

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Phase I / Phase II Interventional United States, China +12

Myeloid Leukemia, Philadelphia Positive

Recruiting NCT07298044☆ Save

A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis

Phase IV Interventional Austria, Belgium +2

Transthyretin Amyloid Cardiomyopathy

Not yet recruiting NCT07674212☆ Save

Take5Care+: A Self-management Educational Intervention

No phase Interventional —

Hematologic Neoplasms

Recruiting NCT03571321☆ Save

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Phase I Interventional United States

Acute Lymphoblastic Leukemia · ALL, Childhood · ALL

Recruiting NCT06333899☆ Save

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Early Phase I Interventional United States, Australia +4

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Recruiting NCT07596823☆ Save

Hematological Indices and Sympathetic Block Response in Neuropathic Pain

— Observational Turkey (Türkiye)

Neuropathic Pain · Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4

Recruiting NCT07123454☆ Save

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase I / Phase II Interventional United States, Australia +6

B-cell Non-Hodgkin Lymphoma

Not yet recruiting NCT07672964☆ Save

CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation

Phase I Interventional China

Hematologic Malignancy · Haplo-identical HCT

Recruiting NCT06815003☆ Save

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Phase II Interventional United States

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia

Recruiting NCT02012699☆ Save

Integrated Cancer Repository for Cancer Research

— Observational United States

Pancreatic Cancer · Thyroid Cancer · Lung Cancer

Not yet recruiting NCT07528417☆ Save

Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)

Phase II Interventional Canada

Myeldysplastic Syndrome (MDS) · MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) · Acute Myeloid Leukemia

Recruiting NCT07006506☆ Save

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Phase II Interventional United States

Graft Versus Host Disease · Graft Vs Host Disease · Hematologic Malignancy

Recruiting NCT07674498☆ Save

Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma

No phase Interventional Belgium

Myeloma Multiple

Recruiting NCT01137825☆ Save

Registry of Older Patients With Cancer

— Observational United States

Chronic Myeloproliferative Disorders · Cognitive/Functional Effects · Leukemia

Recruiting NCT04587687☆ Save

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

Phase II Interventional United States

Recurrent Follicular Lymphoma · Refractory Follicular Lymphoma

Recruiting NCT04989803☆ Save

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Phase I / Phase II Interventional United States, Australia +4

Relapsed and/or Refractory B-cell Lymphoma